National Pension Service Zai Lab LTD Transaction History

National Pension Service

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	BUY	$30.21 - $48.1 $186,818 - $297,450	6,184 Added 33.84%	24,459 $813,000
Q4 2022 Feb 23, 2023	SELL	$22.28 - $38.71 $1,804 - $3,135	-81 Reduced 0.44%	18,275 $561,000
Q4 2022 Feb 17, 2023	SELL	$22.28 - $38.71 $1,804 - $3,135	-81 Reduced 0.44%	18,275 $561,000
Q3 2022 Feb 23, 2023	BUY	$34.2 - $51.69 $2,770 - $4,186	81 Added 0.44%	18,356 $627,000
Q3 2022 Nov 17, 2022	BUY	$34.2 - $51.69 $14,466 - $21,864	423 Added 2.36%	18,356 $644,000
Q2 2022 Aug 17, 2022	BUY	$23.14 - $49.68 $381,393 - $818,825	16,482 Added 1135.91%	17,933 $622,000
Q4 2021 Feb 15, 2022	BUY	$54.9 - $105.21 $79,659 - $152,659	1,451 New	1,451 $91,000

121

46.7M

223K

588K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.43B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of National Pension Service, based on Form 13F filings with the SEC.

Stay updated on National Pension Service with notifications on news.